Balanços • Sanofi

SNY

A Sanofi desenvolve e comercializa medicamentos em imunologia, vacinas e doenças raras. Embora a empresa ofereça diversos medicamentos, seu maior gerador de receita, o Dupixent, responde por cerca de 30% das vendas. Os lucros dessa droga imunológica são divididos com a Regeneron. Cerca de 45% da receita total vem dos EUA, 20% da Europa e 6% da China.

Tabela de balanços completa e atualizada com os principais indicadores financeiros: Lucro Líquido, Receita, EBTIDA, Margem, ROE, Dividendos

Ano	Receita Líq	EBITDA	Lucro Líq	Mrg Líq	LPA Dil	Patrimônio	ROE	Dív Líq Aj	DL/EBITDA Aj	FCO Aj	Capex	FCF	FCL Aj	Recompra	Dividendo	Payout	DY
12/2016	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345
12/2017	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345
12/2018	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345
12/2019	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345
12/2020	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345
12/2021	44,548	13,051	0,234	16%	2.8	78,100	9%	11,608	0.89	11,688	-2,323	-8,024	9,364	-434	-4,612	65%	3.7%
12/2022	43,509	14,234	0,234	21%	3.6	80,219	11%	6,752	0.47	11,040	-2,256	-6,244	8,784	-533	-4,575	51%	3.8%
12/2023	46,007	12,590	0,234	13%	2.4	81,848	7%	8,492	0.67	11,052	-3,212	-8,901	7,840	-656	-4,986	84%	4%
12/2024	46,083	11,278	0,234	13%	2.3	80,651	7%	8,906	0.79	9,160	-3,325	-5,997	5,835	-314	-4,934	85%	4.1%
12/2025	54,810	14,105	0,234	17%	3.7	83,743	11%	12,827	0.91	12,245	-4,151	-9,629	8,094	-5,902	-5,643	62%	4.8%

Para ver a tabela completa, você precisa ser Premium.